Windlas Biotech (NSE:WINDLAS) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:WINDLAS Windlas Biotech Ltd NSE:WINDLAS
90 GF Score
Price ₹851.05
GF Value ₹939.87
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Windlas Biotech Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

NSE:WINDLAS
90GF Score
Windlas Biotech Ltd NSE:WINDLAS
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Windlas Biotech (NSE:WINDLAS) Overvalued in 2026?

Based on GuruFocus' analysis, Windlas Biotech stock appears to be undervalued. The current stock price of ₹851.05 is trading 9.5% below its estimated GF Value™ of ₹939.87. GuruFocus considers Windlas Biotech to be Fairly Valued.

Key valuation signals for NSE:WINDLAS:

  • Dividends Received:
  • GF Value™: ₹939.87 vs. price of ₹851.05 (9.5% below fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the NSE:WINDLAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Windlas Biotech Business Description

Other Exchanges 543329:India
Address Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001
Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
90GF Score

Get the complete analysis for NSE:WINDLAS

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹851.05
Price
₹939.87
GF Value